Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
Three-year follow-up after rotational atherectomy for the treatment of diffuse in-stent restenosis: Predictors of major adverse cardiac events
Autore:
Radke, PW; vom Dahl, J; Hoffmann, R; Klues, HG; Hosseini, M; Janssens, U; Hanrath, P;
Indirizzi:
Univ Hosp Aachen, Med Clin 1, Aachen, Germany Univ Hosp Aachen Aachen Germany osp Aachen, Med Clin 1, Aachen, Germany
Titolo Testata:
CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS
fascicolo: 3, volume: 53, anno: 2001,
pagine: 334 - 340
SICI:
1522-1946(200107)53:3<334:TFARAF>2.0.ZU;2-O
Fonte:
ISI
Lingua:
ENG
Soggetto:
CORONARY-ARTERY DISEASE; BALLOON ANGIOPLASTY; RECURRENT RESTENOSIS; INTERVENTION; MECHANISMS;
Keywords:
stent; restenosis; treatment;
Tipo documento:
Article
Natura:
Periodico
Settore Disciplinare:
Clinical Medicine
Citazioni:
21
Recensione:
Indirizzi per estratti:
Indirizzo: Radke, PW Natl Heart & Lung Inst, Dept Gene Therapy, Imperial Coll Sch Med, Manresa Rd, London SW3 6LR, England Natl Heart & Lung Inst Manresa Rd London England SW3 6LR ngland
Citazione:
P.W. Radke et al., "Three-year follow-up after rotational atherectomy for the treatment of diffuse in-stent restenosis: Predictors of major adverse cardiac events", CATHET C IN, 53(3), 2001, pp. 334-340

Abstract

Restenosis remains the major limitation of coronary stent implantation, especially in diffuse forms of in-stent restenosis. In this study, rotablation (RA) with adjunct angioplasty of in-stent restenosis was performed in 84 patients. Clinical follow-up and control angiography were obtained 6-month postprocedure, The rate of recurrent restenosis after rotablation for in-stent restenosis at 6-month angiographic follow-up was 45%, resulting in a rate of major adverse cardiac events of 35%, At 3-year follow-up, the cumulative event-free survival rate was 57% for the entire population. The only predictor of MACE at 3-year clinical follow-up by multivariate logistic regression analysis was in-stent lesion length. RA for the treatment of diffuse in-stent restenosis is thereby characterized by high procedural success rates and recurrent angiographic restenosis in 45% of patients with diffuse lesions. Major adverse cardiac events occur most likely within the first 6 months postprocedure, Three years after rotablation of in-stent restenosis, 43% of patients had experienced at least one major adverse cardiac event. (C) 2001 Wiley-Liss, Inc.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 26/11/20 alle ore 11:42:30